EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Smart Nanoprobe for Visually Investigating the Activation Effect of Cyclical DOX Release on the p53 Pathway and Pathway-Related Molecules

Ping Sun, Chunlei Gao, Zhe Chen, Siyu Wang, Gang Li, Mingming Luan, Yaoguang Wang iD

Biosensors · 2025

DOI: 10.3390/bios15060383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2025. Verfasst von Ping Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China. Hauptthemen laut MEDLINE: Doxorubicin, Tumor Suppressor Protein p53, Nanoparticles. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing appropriate methods for real-time in situ investigation of how drugs influence signaling pathways and related biomolecules holds enormous potential for helping to provide an understanding of how anticancer drugs exert their effects. Herein, we report a smart nanoprobe, PDA-MB (DOX)-Pep, constructed on the basis of polydopamine nanoparticles (PDA NPs) modified with a dense shell of molecular beacon (MB) with embedded doxorubicin (DOX) and peptide, which can respond specifically to miRNA-34a and Caspase-3 targets. Intracellular experiments demonstrated that, in comparison to the control nanoprobe PDA-MB-Pep, the smart nanoprobe could selectively respond to miRNA-34a, facilitating the release of the embedded DOX. The released DOX subsequently activated the p53 pathway, which further upregulated miRNA-34a expression, leading to additional DOX release. This initiated a cyclical process involving the probe’s response to miRNA-34a, DOX release, p53 activation, and miRNA-34a upregulation, ultimately enhancing cell apoptosis and increasing Caspase-3 expression. The designed smart nanoprobe offers a visual approach to explore how anticancer drugs influence signaling pathways and related molecules at the cellular level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinTumor Suppressor Protein p53NanoparticlesHumansMicroRNAsSignal TransductionPolymersApoptosisCaspase 3Indoles

Stichwörter der Autor:innen

apoptosisfluorescent nanoprobemiRNA-34ap53 pathway activationvisual imaging

Substanzen

DoxorubicinTumor Suppressor Protein p53MicroRNAspolydopaminePolymersCaspase 3IndolesMIRN34 microRNA, human

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250353, China.
  • Shanghai Wanhou Biotechnology Co., Ltd., Shanghai 201815, China.

ORCID-Profile: Yaoguang Wang

Förderung

  • National Natural Science Foundation of China
  • Shandong Provincial Natural Science Foundation

Zitieren

APA

Sun, P., Gao, C., Chen, Z., Wang, S., Li, G., Luan, M., & Wang, Y. (2025). A Smart Nanoprobe for Visually Investigating the Activation Effect of Cyclical DOX Release on the p53 Pathway and Pathway-Related Molecules. Biosensors. https://doi.org/10.3390/bios15060383

Vancouver

Sun P, Gao C, Chen Z, Wang S, Li G, Luan M, et al. A Smart Nanoprobe for Visually Investigating the Activation Effect of Cyclical DOX Release on the p53 Pathway and Pathway-Related Molecules. Biosensors. 2025. doi:10.3390/bios15060383

BibTeX
@article{Sun2025,
  author = {Sun, Ping and Gao, Chunlei and Chen, Zhe and Wang, Siyu and Li, Gang and Luan, Mingming and Wang, Yaoguang},
  title = {A Smart Nanoprobe for Visually Investigating the Activation Effect of Cyclical DOX Release on the p53 Pathway and Pathway-Related Molecules},
  journal = {Biosensors},
  year = {2025},
  doi = {10.3390/bios15060383}
}
Kostenlos starten →